Core Scientific (CORZ) Asset Writedowns and Impairment (2022 - 2026)

Core Scientific (CORZ) has 4 years of Asset Writedowns and Impairment data on file, last reported at $266.5 million in Q1 2026.

• Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $266.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $277.8 million (changed N/A YoY) and the FY2025 annual result came in at $11.4 million, changed N/A from the prior year.
• Asset Writedowns and Impairment improved to $266.5 million in Q1 2026 per CORZ's latest filing, from $11.4 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $790.8 million in Q2 2022, with the low at -$784.8 million in Q3 2022.
• Average Asset Writedowns and Impairment over 4 years is $41.0 million, with a median of $11.4 million recorded in 2025.
• The widest YoY moves for Asset Writedowns and Impairment: up 111.68% in 2025, down 111.68% in 2025.
• Core Scientific's Asset Writedowns and Impairment stood at $3.1 million in 2022, then sank by 3277.43% to -$97.3 million in 2024, then jumped by 111.68% to $11.4 million in 2025, then soared by 2246.05% to $266.5 million in 2026.
• Business Quant data shows CORZ's Asset Writedowns and Impairment at $266.5 million in Q1 2026, $11.4 million in Q4 2025, and -$97.3 million in Q4 2024.